- A third of the clinical trial results that federal regulators reviewed to approve drugs made by large pharmaceutical companies in 2012 were never publicly reported, according to a new study that grades companies on their transparency. https://www.washingtonpost.com/news/wonk/wp/2015/11/12/how-pharma-keeps-a-trove-of-drug-trials-out-of-public-view/ 22 comments science
Linked pages
Related searches:
Search whole site: site:washingtonpost.com
Search title: How pharma keeps a trove of drug trials out of public view - The Washington Post
See how to search.